Quest Laboratories Ltd

QUESTLAB NSE Healthcare Pharmaceuticals
₹137.50
-1.47%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.08.
  • Comfortable interest cover: operating profit covers interest about 9 times.
  • Return on equity is healthy at 16.8%.
  • Return on capital employed is healthy at 18.4%.
  • Net profit margin is 13.4%.
  • Profit has compounded about 87% a year over five years.
  • Sales have compounded about 30% a year over five years.
  • Promoters hold a majority stake (66.78%).

!Watch-points

  • Recent profit growth (11%) is slower than the five-year pace (87%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.3

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
5 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 225 Cr
Current Price₹ 137.50
High / Low₹ 152.60 / 81.30
Stock P/E15.010918
Book Value₹ 59.10
Dividend Yield0%
ROCE18.40%
ROE16.80%
Face Value₹ 10.00
Debt to Equity0.08
PEG Ratio0.21
EV / EBITDA7.74
Industry PE35.70
P/B Ratio2.506654
EPS₹ 9.17
Debt₹ 8 Cr
PAT Margin13.39%
Cash PAT₹ 16 Cr
ICR9.00
Promoter Holding66.78%
FII Holding0.61%
DII Holding2.04%
Public Holding30.56%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 30.00%
3 Years 22.00%
TTM 8.00%
Compounded Profit Growth
10 Years
5 Years 87.00%
3 Years 44.00%
TTM 11.00%
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year -13.00%
Return on Equity
10 Years
5 Years 26.00%
3 Years 23.00%
Last Year 17.00%
Educational data only. Not a recommendation to buy, sell or hold any security.